Davinder Singh Brar

Chairman at Aragen Life Sciences Pvt Ltd.

Davinder Singh Brar

Davinder Singh Brar

Chairman at Aragen Life Sciences Pvt Ltd.

Overview
Career Highlights

Aragen Life Sciences Pvt Ltd.
Ranbaxy Laboratories Limited

RelSci Relationships

883

Number of Boards

16

Birthday

08/1952

Age

69

Relationships
RelSci Relationships are individuals Davinder Singh Brar likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Operating Officer at Aragen Life Sciences Pvt Ltd.

Relationship likelihood: Strong

Former Executive Vice President, Pharmaceutical Operations at Eli Lilly & Company

Relationship likelihood: Strong

Chief Executive Officer & Director at Aragen Life Sciences Pvt Ltd.

Relationship likelihood: Strong

Founder at Wockhardt Ltd.

Relationship likelihood: Strong

Chief Executive Officer, MD & Executive Director at Maruti Suzuki India Limited

Relationship likelihood: Strong

Head, Analytical Services at Aragen Life Sciences Pvt Ltd.

Relationship likelihood: Strong

Head, Supply Chain at Aragen Life Sciences Pvt Ltd.

Relationship likelihood: Strong

Former Executive Director & Production Director at Maruti Suzuki India Limited

Relationship likelihood: Strong

Chief Executive Officer & Managing Director at Mphasis Ltd.

Relationship likelihood: Strong

Trustee & Chief Executive Officer at Wockhardt Ltd.

Relationship likelihood: Strong

Paths to Davinder Singh Brar
Potential Connections via
Relationship Science
You
Davinder Singh Brar
Chairman at Aragen Life Sciences Pvt Ltd.
Education
Masters in Management
Class of 1974

The Faculty of Management Studies focuses on management education more than just business management. The commitment is thought leadership with a deep understanding of business. The approach to pedagogy combines fieldwork, case studies and instrumented feedback with a strong emphasis on concepts and theory. The intent is to encourage intellectual curiosity and open minds to the adventure of ideas. But much about the school is not just about what is taught within its confines. FMS has the unique privilege to be part of one of the premier universities world the University of Delhi - with some of the finest departments in Economics, Law, Sociology, Commerce and Operations Research. Our collaborative approach involves inputs from various departments which gives the benefit of a much wider view and deeper understanding. This is indicated by the success of our alumni who are in positions of leadership in industries & governments across the world. The network of more than 10000 alumni gives students unmatched access to information, mentors and careers. FMS rewards initiative, novelty and thinking outside the box. Our students are individualists of enormous intellectual energy with a talent for collaboration and teamwork. We are a diverse lot, possessing flair and dynamism that develops in a metropolis like Delhi and thrives on challenges both inside and outside the classroom. Corporate recruiters value our graduates for their intellectual abilities, their collaborative mind-set, their individuality and their ability to hit the ground running.

BE in Electrical

The Thapar University is today recognized among the leading privately managed engineering institutions of the country and the best of its kind in the north-western region of India. NAAC, an Autonomous Institution of UGC, has reaccredited Thapar University and award A Grade. The TTC with its three institutions viz, TU, TP and TCIRD, is today a unique Campus in our country with extraordinary potential for development of indigenous technology and its engineering industries. A Centre of Relevance and Excellence (CORE) has been set up at Thapar University by TIFAC Mission REACH of Department of Science & Technology, Govt. of India in its first phase of setting up eight CORES at various Institutes and Universities spread all over the country. Science and Technology Entrepreneur’s Park (STEP) has been established jointly by Thapar University and DST, Govt. of India. Thapar University has impressively grown in size and activities during the last five decades of its existence. Nearly 10,500 engineers have left its portals so far, distinguishing themselves as proud Thaparians in diverse fields in our country and aboard. As a fitting recognition of its pioneering role in promoting the growth and development both at National and International levels, Thapar University was granted full autonomy and the status of a Deemed University in 1985 UGC.

Memberships
Member
Prior

Federation of Indian Chambers of Commerce & Industry is the largest and oldest apex business organisation in India, established in 1927. Its history is closely interwoven with India’s struggle for independence, its industrialization, and its emergence as one of the most rapidly growing global economies. FICCI has contributed to this historical process by encouraging debate, articulating the private sector’s views and influencing policy. A non-government, not-for-profit organisation, FICCI is the voice of India’s business and industry.

Career History
Chairman
2004 - Current

Aragen Life Sciences Pvt Ltd. provides research and development services to pharmaceutical and biotechnology companies. Its services include informatics, analytical services, clinical pharmacology, clinical research, chemistry and biology services, process research and development and custom manufacturing, and integrated programs. The company was founded on April 2, 2001 and is headquartered in Hyderabad, India.

Senior Vice President, Sun Pharmaceutical Global Operations
Current

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Senior Advisor
Prior - 2015

KKR invests in companies located across the globe. The firm focuses on telecom, media & technologies, healthcare, infrastructure and real estate sectors. It provides financing for traditional management buyouts, build-ups and growth capital requirements in both private and public companies. It also makes minority and majority investments.

Boards & Committees
Director
Prior

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. It carries out its operations through the following geographic segments: USA, India, Europe, Canada, Australia, and Rest of World. The company was founded by P. V. N. Raju in 1978 and is headquartered in Hyderabad, India.

Director
Prior

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Director
Prior

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Political Donations
$2,500
2012

Former Board Chair & President at The Lugar Center

Investments
Details Hidden

I2india Holdings Ltd. operates as a technology commercialization and investment company. It invests in patents and intellectual property rights in health care and clean tech. The company is headquartered in Mumbai, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Davinder Singh Brar. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Davinder Singh Brar's profile does not indicate a business or promotional relationship of any kind between RelSci and Davinder Singh Brar.